Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO00396)
Xenobiotics Name
Gentamicin
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Approved/Marketed Drug
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3467"></iframe>
3D MOL 2D MOL
PubChem CID
3467
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
D-Lactate dehydrogenase (ldhA) DME Info Pseudomonas aeruginosa [1]
Arylamine N-acetyltransferase (NAT) DME Info Pseudomonas aeruginosa [1]
NADPH-dependent oxidoreductase (nfrA) DME Info Staphylococcus aureus [1]
Hydroxybenzoate 3-monooxygenase (pobA) DME Info Pseudomonas aeruginosa [1]
DME(s) Induced by This Xenobiotics
Alpha-L-iduronidase (IDUA) DME Info Homo sapiens [2]
References
1 Lysozyme associated liposomal gentamicin inhibits bacterial biofilm. Int J Mol Sci. 2017 Apr 9;18(4).
2 Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet. 2001 Feb 1;10(3):291-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.